Ledger.Open graph →
SEC Form D · filed March 15, 2023

ONL Therapeutics, Inc

Offering
$15.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ANN ARBOR, MI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Constance Chang · Ann Arbor, MIExecDavid Zacks · Ann Arbor, MIExec · DirectorStella Robertson · Ann Arbor, MIDirectorMark Hooper · Ann Arbor, MIDirectorBill Burns · Ann Arbor, MIDirectorDavid Esposito · Ann Arbor, MIExec · DirectorSampson L. Glassman · Winchester, VADirectorSeth E. Roderick · Harrisonburg, VAExecMiguel E. Prendens · Winchester, VADirectorSean E. Foster · San Juan, Puerto RicoExec · DirectorMichael Turner · Winchester, VADirectorGreg E. White · Fernandina Beach, FLExec · DirectorAri A. Santiago · Clayton, MODirectorHarold A. Thomas, Jr · Clayton, MOExecJames L. Alt · New York, NYExec · DirectorMichael L. Appel · New York, NYDirectorDavid Tingley · Naples, FLExec · DirectorPalisade Partners, Inc · Englewood, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗